Pharmacological targeting of the constitutively activated MEK/MAPK-dependent signaling pathway in glioma cells inhibits cell proliferation and migration

  • Authors:
    • Alexander Glassmann
    • Karl Reichmann
    • Björn Scheffler
    • Martin Glas
    • Nadine Veit
    • Rainer Probstmeier
  • View Affiliations

  • Published online on: August 17, 2011     https://doi.org/10.3892/ijo.2011.1165
  • Pages: 1567-1575
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Activated mitogen-activated protein kinase MAPK cascade leading to ERK1/2 phosphorylation is expressed in the majority of glial neoplasms and negatively correlates with survival time of patients. Here we show that ERK1/2 kinases are constitutively activated in glioma cell lines and stem cell-enriched primary cultures of glioblastoma. Pharmacological targeting of the activated MEK/ERK1/2 module with the MEK inhibitor U0126 attenuates cell cycle progression (11 out of 11 cell lines), impairs single (7 out of 10) and collective cell migration (9 out of 11) and abolishes single cell emigration from monolayers (4 out of 9). Attacking the activated MEK/ERK1/2 module thus partially blocks the tumorigenic potential of glial cancer cells on different levels and strongly suggests the application of combination molecularly targeted therapies to interfere more efficiently with glial tumor development and progression.

Related Articles

Journal Cover

December 2011
Volume 39 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Glassmann, A., Reichmann, K., Scheffler, B., Glas, M., Veit, N., & Probstmeier, R. (2011). Pharmacological targeting of the constitutively activated MEK/MAPK-dependent signaling pathway in glioma cells inhibits cell proliferation and migration. International Journal of Oncology, 39, 1567-1575. https://doi.org/10.3892/ijo.2011.1165
MLA
Glassmann, A., Reichmann, K., Scheffler, B., Glas, M., Veit, N., Probstmeier, R."Pharmacological targeting of the constitutively activated MEK/MAPK-dependent signaling pathway in glioma cells inhibits cell proliferation and migration". International Journal of Oncology 39.6 (2011): 1567-1575.
Chicago
Glassmann, A., Reichmann, K., Scheffler, B., Glas, M., Veit, N., Probstmeier, R."Pharmacological targeting of the constitutively activated MEK/MAPK-dependent signaling pathway in glioma cells inhibits cell proliferation and migration". International Journal of Oncology 39, no. 6 (2011): 1567-1575. https://doi.org/10.3892/ijo.2011.1165